Management of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in a Jehovah’s Witness using chemotherapy free regimen: A case report and review of literature

Chemo-free approach is a promising opportunity to treat Jehovah's witnesses with pH-positive B cell ALL as the haemoglobin and platelets remained above transfusion thresholds. However, further research is required to fully understand and implement this approach. Future clinical trials should consider including this unique patient population to better understand their needs and improve outcomes.

Authors

Institutions

Publication Details

Journal
Leukemia Research Reports
Published
2025-01-01
DOI
https://doi.org/10.1016/j.lrr.2025.100517
Primary Topic
Chronic Myeloid Leukemia Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Management of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in a Jehovah’s Witness using chemotherapy free regimen: A case report and review of literature

Eshan Khan, Muhammad Hassan Raza, Salman Fazal, Alexis M Desjarlais
1 links
Leukemia Research Reports
Chronic Myeloid Leukemia Treatments
article

Management of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in a Jehovah’s Witness using chemotherapy free regimen: A case report and review of literature

Eshan Khan, Muhammad Hassan Raza, Salman Fazal, Alexis M Desjarlais
article en

Abstract

Chemo-free approach is a promising opportunity to treat Jehovah's witnesses with pH-positive B cell ALL as the haemoglobin and platelets remained above transfusion thresholds. However, further research is required to fully understand and implement this approach. Future clinical trials should consider including this unique patient population to better understand their needs and improve outcomes.

Leukemia Research ReportsVol. 24
Allegheny Health Network (US), Nishtar Medical College and Hospital (PK), Allegheny General Hospital (US), Drexel University (US)
Openalex Percentile: Top 84%
Chronic Myeloid Leukemia Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.